Search results
Displaying Results 1151-1160 of 13853 for "❤️推荐三上悠亚唯一无码作品，请访问 【】❤️推荐"
Chinese COVID-19 vaccine developer Clover files for IPO
Clover Biopharmaceuticals, a Chinese pre-revenue drug developer that has raised $315 million across several funding rounds since 2011, has filed for a Hong Kong IPO.
Blackstone to cement control of India's Mphasis
The Blackstone Group is set to lift its controlling position in India-listed IT services provider Mphasis to 75% as part of a deal worth up to $2.8 billion.
Sequoia joins $25m Series D for Singapore's StashAway
Sequoia Capital India has joined a S$33.3 million ($25 million) Series D round for Singapore-based wealth management platform StashAway.
Hong Kong e-commerce tracking start-up secures $66m
AfterShip, a Hong Kong-based e-commerce tracking service provider, has raised a $66 million Series B led by Tiger Global Management. GL Ventures also took part.
Blackstone in $3.1b first close on second Asia PE fund
The Blackstone Group has reached a first close of $3.1 billion on its second dedicated Asia private equity fund, which is already larger than Fund I.
New Zealand dairy farm management start-up raises $23m
Blackbird Ventures has led a NZ$32 million ($23.4 million) Series B round for Halter, a New Zealand-based start-up that has developed smart cow collars and an accompanying app to aid dairy farm management.
Rising Japan exits staffing services business
Rising Japan Equity, a domestic private equity firm, has agreed to sell Progress, a staffing and contracting services provider, to listed staffing solutions business UT Group for JPY3.09 billion ($28.6 million).
Tiger Global invests $25m in India crypto app
Tiger Global Management has invested $25 million in CoinSwitch Kuber, a cryptocurrency exchange for the Indian retail market that facilitates investments as small as INR100 ($1.33).
China data analytics start-up Kyligence raises $70m
Kyligence, a China-based data analytics business, has closed a $70 million Series D round led by SPDB International.
Loyal Valley leads Series B extension for China's Edigene
Loyal Valley Capital has led a RMB400 million ($62 million) Series B extension for EdiGene, a China-based biotech company that uses genome editing technologies to accelerate drug discovery.